Opportunity Information: Apply for PAR 09 025

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "National Cancer Institute Program Project (P01) Applications" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control.
  • This funding opportunity was created on Nov 12, 2008 and posted on Nov 12, 2008.
  • Applicants must submit their applications by Jan 4, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Public and State controlled institutions of higher education Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments.
  • Other Eligible Applicants include the following Eligible Agencies of the Federal Government Regional Organizations U.S. Territory or Possession Units of Local Governments.
Apply for PAR 09 025

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), issued this funding opportunity announcement to support investigator-initiated Program Project Grants (P01). The main idea is to fund coordinated, multi-project research programs that tackle important cancer-related questions under a shared scientific umbrella. Applicants can propose work in essentially any major area of cancer research, including cancer biology, treatment, detection and diagnosis, prevention, and cancer control. The announcement is intentionally broad and welcomes basic laboratory research, translational studies that move discoveries toward clinical use, clinical research involving patients, and population-based studies that examine cancer patterns, risk factors, interventions, and outcomes in communities.

A key structural requirement is that each P01 application must include at least three component research projects. These projects are not meant to be separate, unrelated studies; they must be connected by a common central theme, focus, and/or overall objective. In other words, reviewers will expect the proposed projects to reinforce each other scientifically, creating a combined program that is stronger and more impactful than the same projects funded independently. This is the defining feature of the P01 mechanism: it supports team-based science organized around a unifying goal, rather than a single-investigator, single-project approach.

The mechanism of support is the NIH Program Project (P01) grant. Funding decisions and the number of awards are not guaranteed; awards depend on the availability of appropriated funds and on whether enough high-quality, meritorious applications are received. The opportunity is categorized as discretionary grant funding and is aligned with multiple NIH cancer-related CFDA numbers, reflecting the wide range of research topics it can cover (including causes and prevention, detection and diagnosis, treatment, biology, and control). There is no cost sharing or matching requirement stated for applicants, meaning applicants are not required to provide matching funds as a condition of eligibility.

Eligibility is broad and includes many types of organizations that commonly participate in biomedical research. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with 501(c)(3) status and certain nonprofits without 501(c)(3) status), for-profit organizations other than small businesses, and state governments. The eligibility language also extends to additional entities such as eligible federal agencies, regional organizations, U.S. territories or possessions, and units of local government. This breadth is consistent with NIH practice and is meant to ensure that a wide range of capable research institutions and organizations can compete.

Administratively, the opportunity is identified as PAR-09-025, posted on November 12, 2008, with an original and current closing date of January 4, 2012, and an archive date of February 4, 2012. The full announcement was made available through the NIH grants guidance site. For technical issues accessing the announcement or problems with links, the listed point of contact is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This is a National Cancer Institute (NCI), National Institutes of Health (NIH) funding opportunity announcement supporting investigator-initiated Program Project Grants (P01) for cancer-related research organized under a shared scientific umbrella.

Which agency is offering this grant?

The National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), issued the announcement.

What is the grant mechanism being used?

The mechanism of support is the NIH Program Project (P01) grant.

What is the main purpose of a P01 Program Project Grant in this announcement?

The purpose is to support coordinated, multi-project research programs that address important cancer-related questions through a unified, team-based approach rather than separate, stand-alone projects.

What types of cancer research topics are allowed?

The announcement is intentionally broad and allows proposals in essentially any major area of cancer research, including cancer biology, treatment, detection and diagnosis, prevention, and cancer control.

Are both basic and applied research approaches supported?

Yes. The announcement welcomes basic laboratory research, translational studies, clinical research involving patients, and population-based studies examining cancer patterns, risk factors, interventions, and outcomes in communities.

How many research projects must be included in a P01 application?

Each P01 application must include at least three component research projects.

Can the component projects be unrelated if they are all about cancer?

No. The projects are not meant to be separate, unrelated studies. They must be connected by a common central theme, focus, and/or overall objective.

What do reviewers expect regarding how the component projects fit together?

Reviewers will expect the projects to reinforce each other scientifically and to form a combined program that is stronger and more impactful than the same projects funded independently.

Is this opportunity limited to a specific cancer subfield or disease site?

No. The opportunity is described as broad and covers multiple major areas of cancer research without restricting applicants to a single subfield.

Is cost sharing or matching required?

No. The announcement states there is no cost sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of eligibility.

Who is eligible to apply?

Eligibility is broad and includes: public and state-controlled institutions of higher education; private institutions of higher education; nonprofit organizations (including 501(c)(3) organizations and certain nonprofits without 501(c)(3) status); for-profit organizations other than small businesses; and state governments.

Are local government entities or U.S. territories eligible?

Yes. The eligibility language extends to entities such as U.S. territories or possessions and units of local government.

Are federal agencies eligible to apply?

Yes. The eligibility language includes eligible federal agencies.

Are regional organizations eligible to apply?

Yes. Regional organizations are included in the eligibility language.

Is funding guaranteed if an application is submitted?

No. Funding decisions and the number of awards are not guaranteed. Awards depend on the availability of appropriated funds and on receiving enough high-quality, meritorious applications.

What kind of funding category is this?

The opportunity is categorized as discretionary grant funding.

Does this opportunity align with specific NIH cancer-related program areas?

Yes. It is aligned with multiple NIH cancer-related CFDA numbers, reflecting the wide range of topics it can cover (including causes and prevention, detection and diagnosis, treatment, biology, and control).

What is the funding opportunity announcement (FOA) number?

The opportunity is identified as PAR-09-025.

When was this FOA posted?

It was posted on November 12, 2008.

What are the closing dates for this opportunity?

The original and current closing date listed is January 4, 2012.

When was this opportunity archived?

The archive date is February 4, 2012.

Where was the full announcement made available?

The full announcement was made available through the NIH grants guidance site.

Who should be contacted for technical issues accessing the announcement or problems with links?

For technical issues, the listed point of contact is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Gang Resistance Education And Training (G.R.E.A.T.) Program Regional Training Centers

Previous opportunity: FWS ECON ACES 2008

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 09 025

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 09 025) also looked into and applied for these:

Funding Opportunity
Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 09 026

Funding Number: PAR 09 026
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Education Programs of Excellence in Scientifically Validated Behavioral Treatment (R25) Apply for RFA MH 09 110

Funding Number: RFA MH 09 110
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Shared Instrumentation Grant Program (S10) Apply for PAR 09 028

Funding Number: PAR 09 028
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Mutant Mouse Regional Resource Centers (Limited Competition U42) Apply for RFA RR 09 003

Funding Number: RFA RR 09 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mutant Mouse Regional Resource Centers (U42) Apply for RFA RR 09 002

Funding Number: RFA RR 09 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $750,000
STUDIES OF ENERGY BALANCE AND CANCER IN HUMANS Apply for PA 04 124

Funding Number: PA 04 124
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows (F31) in Nursing Research Apply for PAR 05 091

Funding Number: PAR 05 091
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
IDeA Networks of Biomedical Research Excellence (INBRE) P20 Apply for PAR 08 150

Funding Number: PAR 08 150
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 08 225

Funding Number: PAR 08 225
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50) Apply for PAR 08 020

Funding Number: PAR 08 020
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
National Cooperative Drug Discovery and Development Groups (NCDDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01/U19) Apply for PAR 08 238

Funding Number: PAR 08 238
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Etiology, Prevention, and Treatment of Hepatocellular Carcinoma (P01) Apply for PAR 08 245

Funding Number: PAR 08 245
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biomedical Technology Research Resource (P41) Apply for PAR 08 259

Funding Number: PAR 08 259
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Diversity promoting Institutions Drug Abuse Research Program (DIDARP) (R24) Apply for PAR 09 011

Funding Number: PAR 09 011
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium (Limited Competition) U01 Apply for RFA CA 09 503

Funding Number: RFA CA 09 503
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20) Apply for RFA DA 09 012

Funding Number: RFA DA 09 012
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research Education Grants for Statistical Training in the Genetics of Addiction (R25) Apply for PAR 08 081

Funding Number: PAR 08 081
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
SBIR Phase II Bridge Awards to Accelerate the Development of New Cancer Therapies and Cancer Imaging Technologies Toward Commercialization (SBIR R44) Apply for RFA CA 08 021

Funding Number: RFA CA 08 021
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NINR AREA for Health Disparities Research at Minority Serving Institutions (MSIs ) (R15) Apply for PA 08 171

Funding Number: PA 08 171
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NIDA Research Center of Excellence Grant Program (P50) Apply for PAR 08 046

Funding Number: PAR 08 046
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 09 025", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.